Kenneth J. Krogulski's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 124 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 124 | 294,870 (1%) | 0% | 2.2 | 278 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 124 | 294,746 (1%) | 0% | 2.4 | 293 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 124 | 295,242 (1%) | 0% | 2.3 | 290 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 124 | 295,118 (1%) | 0% | 2.3 | 281 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 124 | 294,994 (1%) | 0% | 2.3 | 279 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,970 (1%) | 0% | 3.3 | 340 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,866 (1%) | 0% | 2.8 | 293 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,762 (1%) | 0% | 2.5 | 260 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,658 (1%) | 0% | 2.6 | 266 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,554 (1%) | 0% | 2.6 | 270 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,450 (1%) | 0% | 2.3 | 241 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 104 | 295,346 (1%) | 0% | 2.4 | 250 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 67 | 296,104 (1%) | 0% | 4.2 | 281 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 67 | 296,037 (1%) | 0% | 3.7 | 245 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 62 | 296,538 (1%) | 0% | 3.9 | 242 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 54 | 296,476 (1%) | 0% | 3.9 | 213 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 54 | 296,422 (1%) | 0% | 4.0 | 217 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 54 | 296,368 (1%) | 0% | 4.2 | 227 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 54 | 296,314 (1%) | 0% | 4.3 | 230 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 54 | 296,260 (1%) | 0% | 4.1 | 223 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 52 | 296,156 (1%) | 0% | 4.2 | 218 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Dec 2025 | 50 | 296,206 (1%) | 0% | 4.3 | 216 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 124 | 294,622 (1%) | 0% | 2.4 | 299 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 124 | 294,498 (1%) | 0% | 2.2 | 269 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 124 | 294,374 (1%) | 0% | 2.2 | 274 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 124 | 294,250 (1%) | 0% | 2.1 | 260 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 117 | 294,126 (1%) | 0% | 2.0 | 229 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 117 | 294,009 (1%) | 0% | 2.0 | 233 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 117 | 293,892 (1%) | 0% | 2.0 | 235 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 117 | 293,775 (1%) | 0% | 2.0 | 232 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 117 | 293,658 (1%) | 0% | 2.2 | 254 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 110 | 293,541 (1%) | 0% | 2.2 | 237 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 110 | 293,431 (1%) | 0% | 2.2 | 239 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 110 | 293,321 (1%) | 0% | 2.0 | 219 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 110 | 293,211 (1%) | 0% | 2.1 | 227 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 110 | 293,101 (1%) | 0% | 2.1 | 232 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 96 | 292,895 (1%) | 0% | 2.3 | 218 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 96 | 292,991 (1%) | 0% | 2.2 | 210 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 68 | 292,799 (1%) | 0% | 2.5 | 172 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 68 | 292,731 (1%) | 0% | 2.8 | 192 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 03 Nov 2025 | 68 | 292,663 (1%) | 0% | 2.8 | 190 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,167 (1%) | 0% | 3.3 | 223 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,595 (1%) | 0% | 3.4 | 231 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,527 (1%) | 0% | 3.3 | 224 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,459 (1%) | 0% | 3.3 | 222 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,391 (1%) | 0% | 3.3 | 223 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,323 (1%) | 0% | 3.5 | 237 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,255 (1%) | 0% | 3.5 | 239 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,187 (1%) | 0% | 3.4 | 234 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,119 (1%) | 0% | 3.6 | 246 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 292,051 (1%) | 0% | 3.6 | 245 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,983 (1%) | 0% | 3.5 | 239 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,915 (1%) | 0% | 3.5 | 237 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,847 (1%) | 0% | 3.5 | 237 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,779 (1%) | 0% | 3.4 | 229 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,711 (1%) | 0% | 3.4 | 228 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,643 (1%) | 0% | 3.5 | 241 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,575 (1%) | 0% | 3.6 | 244 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,507 (1%) | 0% | 3.6 | 242 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,439 (1%) | 0% | 3.6 | 247 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,371 (1%) | 0% | 3.2 | 217 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,303 (1%) | 0% | 3.1 | 214 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,235 (1%) | 0% | 3.3 | 221 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 01 Oct 2025 | 68 | 291,099 (1%) | 0% | 3.3 | 225 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 68 | 291,031 (1%) | 0% | 3.1 | 212 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 68 | 290,963 (1%) | 0% | 3.1 | 214 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,647 (1%) | 0% | 3.3 | 204 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 289,779 (1%) | 0% | 3.5 | 219 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,895 (1%) | 0% | 3.0 | 189 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,833 (1%) | 0% | 3.1 | 192 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,771 (1%) | 0% | 3.1 | 192 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,709 (1%) | 0% | 3.2 | 199 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 289,841 (1%) | 0% | 3.6 | 222 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,585 (1%) | 0% | 3.3 | 207 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,523 (1%) | 0% | 3.3 | 205 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,461 (1%) | 0% | 3.4 | 210 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,399 (1%) | 0% | 3.5 | 217 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,337 (1%) | 0% | 3.5 | 217 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,275 (1%) | 0% | 3.5 | 219 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,213 (1%) | 0% | 3.4 | 211 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,151 (1%) | 0% | 3.4 | 210 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,089 (1%) | 0% | 3.4 | 213 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 290,027 (1%) | 0% | 3.4 | 211 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 289,965 (1%) | 0% | 3.6 | 223 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | 02 Sep 2025 | 62 | 289,903 (1%) | 0% | 3.6 | 223 | Common Stock | |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.44 per share. | 01 Aug 2025 | 68 | 288,413 (1%) | 0% | 3.4 | 234 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Aug 2025 | 68 | 289,717 (1%) | 0% | 3.5 | 235 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.47 per share. | 01 Aug 2025 | 68 | 289,649 (1%) | 0% | 3.5 | 236 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.44 per share. | 01 Aug 2025 | 68 | 289,581 (1%) | 0% | 3.4 | 234 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 01 Aug 2025 | 68 | 289,513 (1%) | 0% | 3.4 | 231 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.32 per share. | 01 Aug 2025 | 68 | 289,445 (1%) | 0% | 3.3 | 226 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.32 per share. | 01 Aug 2025 | 68 | 289,377 (1%) | 0% | 3.3 | 226 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Aug 2025 | 68 | 289,309 (1%) | 0% | 3.3 | 225 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.24 per share. | 01 Aug 2025 | 68 | 289,229 (1%) | 0% | 3.2 | 220 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 01 Aug 2025 | 68 | 289,161 (1%) | 0% | 3.1 | 211 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.01 per share. | 01 Aug 2025 | 68 | 289,093 (1%) | 0% | 3.0 | 205 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 01 Aug 2025 | 68 | 289,025 (1%) | 0% | 2.8 | 193 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.94 per share. | 01 Aug 2025 | 68 | 288,957 (1%) | 0% | 2.9 | 200 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 01 Aug 2025 | 68 | 288,889 (1%) | 0% | 2.9 | 198 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.87 per share. | 01 Aug 2025 | 68 | 288,821 (1%) | 0% | 2.9 | 195 | Common Stock |
| Cumberland Pharma Inc | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 01 Aug 2025 | 68 | 288,753 (1%) | 0% | 3.4 | 231 | Common Stock |